Alzinova to issue units to underwriter in place of part of SEK 3.6 million fee
Alzinova will issue 2,857,141 units worth about SEK 3.6 million to Mangold Fondkommission, paying part of the underwriting fee in units, per Reuters.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Swedish biopharmaceutical company Alzinova AB, which develops treatments for Alzheimer's disease, has decided to issue 2,857,141 units to Mangold Fondkommission AB. The total size of the issue is about SEK 3.6 million. Payment is made by offsetting the underwriter's claim for its fee rather than in cash, according to Reuters.
Each unit consists of three shares, four warrants of series TO5 and three warrants of series TO6. The price is SEK 1.26 per unit, or SEK 0.42 per share, the same as in the completed rights issue. The rest of the underwriter's fee, SEK 1.92 million, will be paid in cash. The issue raises the share count from 307,487,998 to 316,059,421, a dilution of about 2.7 percent.
CEO Tord Labuda said: "We are very pleased that the majority of the guarantee fee is being paid in units rather than cash."
why it matters
The deal is small and mainly affects existing shareholders through dilution. Paying part of the fee in units rather than cash preserves liquidity, which the board said has a positive effect on the company's finances.
tags
instruments
sources
- Alzinova's Board Resolves On Directed Issue Of Units — Reuters, 20 October 2026 at 05:32 UTC
- Alzinova’s Board of Directors resolves on a directed issue of units to underwriters in connection with the completed rights issue — TradingView, 20 October 2026 at 05:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗